25
Participants
Start Date
December 2, 2016
Primary Completion Date
March 12, 2020
Study Completion Date
September 22, 2022
Comprehensive Geriatric Assessment
Ancillary studies
Laboratory Biomarker Analysis
Correlative studies
Neratinib
Given PO
Pharmacological Study
Correlative studies
City of Hope Medical Center, Duarte
City of Hope South Pasadena, South Pasadena
City of Hope Mission Hills, Mission Hills
City of Hope Rancho Cucamonga, Rancho Cucamonga
City of Hope West Covina, West Covina
City of Hope Corona, Corona
City of Hope Antelope Valley, Lancaster
National Cancer Institute (NCI)
NIH
City of Hope Medical Center
OTHER